Status:
COMPLETED
Hemogram Parameter Changes With Sepsis Filter
Lead Sponsor:
Samsun University
Conditions:
Platelet Abnormality
Renal Failure
Eligibility:
All Genders
18+ years
Brief Summary
Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflamma...
Eligibility Criteria
Inclusion
- Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters
Exclusion
- -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06948630
Start Date
January 1 2024
End Date
February 1 2024
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istinye University
Istanbul, Turkey (Türkiye)